Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Year End Update and Board Change

13 Dec 2017 07:00

RNS Number : 1571Z
IDOX PLC
13 December 2017
 

Idox plc

("Idox", the "Company" or the "Group")

Year End Update and Board Change

Idox plc (AIM: IDOX), a leading supplier of specialist information management solutions and services, today provides a further update on results for its financial year ended 31 October 2017 (further to the announcement dated 14 November 2017).

Following internal review in preparation for the full year audit, the Company has identified a small number of revenue items that it does not consider should be recognised in the FY2017 results, which are expected to reduce EBITDA for FY2017 to approximately £20m (compared to about £23m stated in the announcement of 14 November, and £21.5m in 2016). These matters were identified internally and have been brought to the attention of Idox's auditors by the Company.

Clarification of these issues has been complicated by the sudden absence of Andrew Riley, Idox's CEO, due to illness. Richard Kellett-Clarke, currently a non-Executive Director and former CEO of Idox, has agreed to stand in as Interim CEO pending Andrew's return from sick leave.

 

Final Results

As a result of the matters above, the Board expects that the Company's final results for the 2017 financial year will be announced in February 2018.

This announcement is released by Idox plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR"), encompassing information relating to the update and board change described herein, and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by Jane Mackie, Director.

 

 

Enquiries:

Idox plc +44 (0) 870 333 7101

Laurence Vaughan, Non-Executive Chairman

Richard Kellett-Clarke, Interim Chief Executive

Jane Mackie, Chief Financial Officer

 

N+1 Singer (NOMAD and Broker) +44 (0) 20 7496 3000

Shaun Dobson

Liz Yong

 

MHP (Financial PR) +44 (0) 20 3128 8100

Reg Hoare

Andrew Leach

Charlie Barker

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDTTBTTMBABTJR
Date   Source Headline
29th May 20267:00 amRNSCancellation - IDOX Plc
26th May 20261:45 pmRNSRule 19.6(b) update
18th May 202610:22 amRNSHolding(s) in Company
12th May 20268:21 amRNSCompulsory Acquisition of Idox Shares
7th May 20263:52 pmRNSHolding(s) in Company
5th May 20267:00 amRNSAcceptance Level Update
28th Apr 20266:00 pmRNSIDOX
28th Apr 20267:00 amRNSProposed cancellation of Idox shares on AIM
27th Apr 20267:00 amRNSAcceptance Level Update
22nd Apr 20262:26 pmRNSForm 8.3 - Idox plc
22nd Apr 20261:00 pmRNSReplacement: Director/PDMR Shareholding
22nd Apr 202611:24 amRNSDirector/PDMR Shareholding
21st Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
21st Apr 20269:13 amBUSForm 8.3 - [IDOX PLC - 20 04 2026] - (CGWL)
21st Apr 20267:45 amRNSDisclosure Table
21st Apr 20267:00 amRNSOffer Declared Unconditional
20th Apr 20263:46 pmRNSUpdate on Letters of Intent
20th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
20th Apr 20269:12 amBUSForm 8.3 - [IDOX PLC - 17 04 2026] - (CGWL)
20th Apr 20267:00 amRNSAcceptance Level Update
17th Apr 20263:26 pmRNSForm 8.3 - IDOX PLC
17th Apr 20263:25 pmRNSForm 8.3 - Idox plc
17th Apr 20262:10 pmRNSHolding(s) in Company
17th Apr 20261:03 pmRNSForm 8.3 - IDOX PLC
17th Apr 202612:43 pmRNSForm 8.3 - Idox plc
17th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
17th Apr 20269:05 amBUSForm 8.3 - [IDOX PLC - 16 04 2026] - (CGWL)
17th Apr 20267:00 amRNSAcceptance Level Update
17th Apr 20267:00 amRNSForm 8.3 - Idox plc
16th Apr 20263:29 pmRNSForm 8.3 - IDOX PLC
16th Apr 20263:27 pmRNSForm 8.3 - IDOX PLC
16th Apr 20263:12 pmRNSForm 8.3 - Idox plc
16th Apr 20261:15 pmRNSForm 8.3 - IDOX PLC
16th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
16th Apr 20268:51 amBUSForm 8.3 - [IDOX PLC - 15 04 2026] - (CGWL)
16th Apr 20267:00 amRNSSatisfaction of Regulatory Conditions
15th Apr 20263:29 pmRNSForm 8.3 - IDOX PLC
15th Apr 20262:38 pmRNSForm 8.3 - Idox plc
15th Apr 20269:25 amBUSForm 8.3 - [IDOX PLC - 14 04 2026] - (CGWL)
15th Apr 20267:00 amRNSUpdate on Letters of Intent
14th Apr 20264:01 pmRNSForm 8.3 - Idox plc
14th Apr 20263:29 pmRNSForm 8.3 - IDOX PLC
14th Apr 20263:27 pmRNSForm 8.3 - IDOX PLC
14th Apr 20261:29 pmRNSForm 8.3 - IDOX PLC
14th Apr 202612:37 pmRNSForm 8.3 - Idox plc
14th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
14th Apr 202610:04 amBUSForm 8.3 - [IDOX PLC - 13 04 2026] - (CGWL)
14th Apr 20267:00 amRNSUpdate on Letters of Intent
13th Apr 202612:00 pmRNSForm 8.5 (EPT/RI) Idox PLC
13th Apr 202610:46 amBUSForm 8.3 - [IDOX PLC - 10 04 2026] - (CGWL)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.